BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23250356)

  • 21. Jaboticaba berry peel intake prevents insulin-resistance-induced tau phosphorylation in mice.
    Batista ÂG; Soares ES; Mendonça MCP; da Silva JK; Dionísio AP; Sartori CR; da Cruz-Höfling MA; Maróstica Júnior MR
    Mol Nutr Food Res; 2017 Oct; 61(10):. PubMed ID: 28544198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of voluntary treadmill exercise and caloric restriction on tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology fed with Western diet.
    Gratuze M; Julien J; Morin F; Marette A; Planel E
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):452-461. PubMed ID: 28779908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
    Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
    J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.
    Laurent C; Burnouf S; Ferry B; Batalha VL; Coelho JE; Baqi Y; Malik E; Mariciniak E; Parrot S; Van der Jeugd A; Faivre E; Flaten V; Ledent C; D'Hooge R; Sergeant N; Hamdane M; Humez S; Müller CE; Lopes LV; Buée L; Blum D
    Mol Psychiatry; 2016 Jan; 21(1):97-107. PubMed ID: 25450226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hippocampal BDNF expression in a tau transgenic mouse model.
    Burnouf S; Belarbi K; Troquier L; Derisbourg M; Demeyer D; Leboucher A; Laurent C; Hamdane M; Buee L; Blum D
    Curr Alzheimer Res; 2012 May; 9(4):406-10. PubMed ID: 22272617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation.
    Kim B; Figueroa-Romero C; Pacut C; Backus C; Feldman EL
    J Biol Chem; 2015 Jul; 290(31):19146-57. PubMed ID: 26100639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
    Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
    Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor.
    Carvalho K; Faivre E; Pietrowski MJ; Marques X; Gomez-Murcia V; Deleau A; Huin V; Hansen JN; Kozlov S; Danis C; Temido-Ferreira M; Coelho JE; Mériaux C; Eddarkaoui S; Gras SL; Dumoulin M; Cellai L; ; Landrieu I; Chern Y; Hamdane M; Buée L; Boutillier AL; Levi S; Halle A; Lopes LV; Blum D
    Brain; 2019 Nov; 142(11):3636-3654. PubMed ID: 31599329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reelin reverts biochemical, physiological and cognitive alterations in mouse models of Tauopathy.
    Rossi D; Gruart A; Contreras-Murillo G; Muhaisen A; Ávila J; Delgado-García JM; Pujadas L; Soriano E
    Prog Neurobiol; 2020 Mar; 186():101743. PubMed ID: 31870804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BIN1 recovers tauopathy-induced long-term memory deficits in mice and interacts with Tau through Thr
    Sartori M; Mendes T; Desai S; Lasorsa A; Herledan A; Malmanche N; Mäkinen P; Marttinen M; Malki I; Chapuis J; Flaig A; Vreulx AC; Ciancia M; Amouyel P; Leroux F; Déprez B; Cantrelle FX; Maréchal D; Pradier L; Hiltunen M; Landrieu I; Kilinc D; Herault Y; Laporte J; Lambert JC
    Acta Neuropathol; 2019 Oct; 138(4):631-652. PubMed ID: 31065832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.
    Przybyla M; van Eersel J; van Hummel A; van der Hoven J; Sabale M; Harasta A; Müller J; Gajwani M; Prikas E; Mueller T; Stevens CH; Power J; Housley GD; Karl T; Kassiou M; Ke YD; Ittner A; Ittner LM
    Brain; 2020 Jun; 143(6):1889-1904. PubMed ID: 32375177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-fat, high-sugar, and high-cholesterol consumption does not impact tau pathogenesis in a mouse model of Alzheimer's disease-like tau pathology.
    Gratuze M; Julien J; Morin F; Calon F; Hébert SS; Marette A; Planel E
    Neurobiol Aging; 2016 Nov; 47():71-73. PubMed ID: 27565300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased tau phosphorylation and impaired brain insulin/IGF signaling in mice fed a high fat/high cholesterol diet.
    Bhat NR; Thirumangalakudi L
    J Alzheimers Dis; 2013; 36(4):781-9. PubMed ID: 23703152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective effect of treadmill exercise against blunted brain insulin signaling, NADPH oxidase, and Tau hyperphosphorylation in rats fed a high-fat diet.
    Jeong JH; Koo JH; Cho JY; Kang EB
    Brain Res Bull; 2018 Sep; 142():374-383. PubMed ID: 30081082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Brain insulin signaling and Tau: impact for Alzheimer's disease and Tauopathies].
    Joly-Amado A; Gratuze M; Benderradji H; Vieau D; Buée L; Blum D
    Med Sci (Paris); 2018 Nov; 34(11):929-935. PubMed ID: 30526837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain network remodelling reflects tau-related pathology prior to memory deficits in Thy-Tau22 mice.
    Degiorgis L; Karatas M; Sourty M; Faivre E; Lamy J; Noblet V; Bienert T; Reisert M; von Elverfeldt D; Buée L; Blum D; Boutillier AL; Armspach JP; Blanc F; Harsan LA
    Brain; 2020 Dec; 143(12):3748-3762. PubMed ID: 33184651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.
    Bomfim TR; Forny-Germano L; Sathler LB; Brito-Moreira J; Houzel JC; Decker H; Silverman MA; Kazi H; Melo HM; McClean PL; Holscher C; Arnold SE; Talbot K; Klein WL; Munoz DP; Ferreira ST; De Felice FG
    J Clin Invest; 2012 Apr; 122(4):1339-53. PubMed ID: 22476196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Learning Impairments, Memory Deficits, and Neuropathology in Aged Tau Transgenic Mice Are Dependent on Leukotrienes Biosynthesis: Role of the cdk5 Kinase Pathway.
    Giannopoulos PF; Chiu J; Praticò D
    Mol Neurobiol; 2019 Feb; 56(2):1211-1220. PubMed ID: 29881943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies.
    Rockenstein E; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Bisquert A; Trejo-Morales M; Spencer B; Masliah E
    PLoS One; 2015; 10(3):e0121570. PubMed ID: 25803611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial effects of exercise in a transgenic mouse model of Alzheimer's disease-like Tau pathology.
    Belarbi K; Burnouf S; Fernandez-Gomez FJ; Laurent C; Lestavel S; Figeac M; Sultan A; Troquier L; Leboucher A; Caillierez R; Grosjean ME; Demeyer D; Obriot H; Brion I; Barbot B; Galas MC; Staels B; Humez S; Sergeant N; Schraen-Maschke S; Muhr-Tailleux A; Hamdane M; Buée L; Blum D
    Neurobiol Dis; 2011 Aug; 43(2):486-94. PubMed ID: 21569847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.